Leukotrienes: One step in our understanding of asthma

Respir Investig. 2019 Mar;57(2):97-110. doi: 10.1016/j.resinv.2018.12.003. Epub 2018 Dec 30.

Abstract

The steps leading to the discovery of leukotrienes and the researchers that played a major part in this long process are presented. The pharmacology of these exquisitely potent compounds shows that they express bronchoconstrictor activity and numerous cellular effects via very specific receptors. Experimental evidence strongly suggests that these mediators play a significant role in asthma physiopathology. Numerous approaches were taken to block their effects on the lungs and this led to the discovery of selected drugs used for asthma treatment. The complexity of this disease and its treatment is emphasized.

Keywords: Asthma mediators; Discovery; Leukotrienes; SRS-A; Slow-reacting substance of anaphylaxis.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Asthma / drug therapy
  • Asthma / etiology*
  • Asthma / metabolism
  • Asthma / pathology
  • Diethylcarbamazine / pharmacology
  • Guinea Pigs
  • Humans
  • Leukotrienes* / metabolism
  • Molecular Targeted Therapy*
  • Prostaglandins / metabolism
  • SRS-A / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Leukotrienes
  • Prostaglandins
  • SRS-A
  • Diethylcarbamazine